Malignant lymphomas in transplantation patients.
作者信息
Penn I, Hammond W, Brettschneider L, Starzl T E
出版信息
Transplant Proc. 1969 Mar;1(1):106-12.
Abstract
摘要
相似文献
1
Malignant lymphomas in transplantation patients.移植患者中的恶性淋巴瘤。
Transplant Proc. 1969 Mar;1(1):106-12.
2
De-novo brain tumours in renal-transplant recipients.肾移植受者的新发脑肿瘤
Lancet. 1971 May 15;1(7707):983-6. doi: 10.1016/s0140-6736(71)91384-5.
3
Cyclophosphamide and whole organ transplantation in human beings.环磷酰胺与人体全器官移植
Surg Gynecol Obstet. 1971 Dec;133(6):981-91.
4
Lymphoma, a complication of renal allotransplantation in man.淋巴瘤，人类同种异体肾移植的一种并发症。
JAMA. 1972 Mar 20;219(12):1593-7.
5
Non-specific and adaptive immunity in renal transplantation.肾移植中的非特异性免疫和适应性免疫
Transplant Proc. 1969 Mar;1(1):283-6.
6
Cyclophosphamide for clinical renal and hepatic transplantation.环磷酰胺用于临床肾和肝移植。
Transplant Proc. 1973 Mar;5(1):511-6.
7
[Malignant tumors following transplantation. Case reports and review of the literature].[移植后恶性肿瘤。病例报告及文献综述]
Schweiz Med Wochenschr. 1973 Apr 21;103(16):577-85.
8
Eight- to ten-year follow-up in early cases of renal homotransplantation.肾同种异体移植早期病例的8至10年随访。
Transplant Proc. 1973 Mar;5(1):787-91.
9
Transplantation of allogeneic tumors in rats and mice treated with azathioprine, prednisone and antilymphocyte serum.用硫唑嘌呤、泼尼松和抗淋巴细胞血清治疗的大鼠和小鼠的同种异体肿瘤移植
Proc Soc Exp Biol Med. 1972 Apr;139(4):1425-8. doi: 10.3181/00379727-139-36377.
10
Immunosuppressive drugs used in clinical renal transplantation.临床肾移植中使用的免疫抑制药物。
Urology. 1977 Jun;9(6 Suppl):52-60.
引用本文的文献
1
Does the Organ Matter in PTLD Development in Solid Organ Transplant Recipients? A Multicenter Observational Study of Risk and Prognostic Factors.实体器官移植受者发生移植后淋巴增殖性疾病时器官是否起作用？一项关于风险和预后因素的多中心观察性研究。
Cancers (Basel). 2025 May 25;17(11):1770. doi: 10.3390/cancers17111770.
2
Azathioprine and risk of non-melanoma skin cancers in organ transplant recipients: a systematic review and update meta-analysis.硫唑嘌呤与器官移植受者非黑色素瘤皮肤癌风险：一项系统评价与更新的荟萃分析
Clin Transl Oncol. 2025 Jan 18. doi: 10.1007/s12094-024-03839-0.
3
Malignancies After Lung Transplantation.肺移植后的恶性肿瘤。
Transpl Int. 2024 Sep 9;37:12127. doi: 10.3389/ti.2024.12127. eCollection 2024.
4
Malignancies After Heart Transplantation.心脏移植后的恶性肿瘤。
Transpl Int. 2024 Sep 9;37:12109. doi: 10.3389/ti.2024.12109. eCollection 2024.
5
Admissions for posttransplant lymphoproliferative disorder: a 9-year longitudinal analysis of the National (Nationwide) Inpatient Sample.移植后淋巴细胞增生性疾病的住院情况：对国家（全国）住院患者样本的9年纵向分析。
Proc (Bayl Univ Med Cent). 2024 Jul 11;37(5):804-812. doi: 10.1080/08998280.2024.2375688. eCollection 2024.
6
Post-Transplant Lymphoproliferative Disorders.移植后淋巴细胞增生性疾病
Semin Nephrol. 2024 Jan;44(1):151503. doi: 10.1016/j.semnephrol.2024.151503. Epub 2024 Mar 22.
7
Global research productivity of post-transplant lymphoproliferative disorder: a bibliometric study.移植后淋巴细胞增生性疾病的全球研究生产力：一项文献计量学研究。
Ann Med Surg (Lond). 2024 Feb 5;86(3):1522-1530. doi: 10.1097/MS9.0000000000001771. eCollection 2024 Mar.
8
Prevention of Oncogenic (EBV and HHV8) Associated Disease in Solid Organ Transplant Recipients.预防实体器官移植受者中与致癌相关的疾病（EBV 和 HHV8）。
Transpl Int. 2023 Nov 17;36:11856. doi: 10.3389/ti.2023.11856. eCollection 2023.
9
Chapter 4: CKD treatment in cancer survivors, from Clinical Practice Guidelines for the Management of Kidney Injury During Anticancer Drug Therapy 2022.第4章：癌症幸存者的慢性肾脏病治疗，摘自《2022年抗癌药物治疗期间肾脏损伤管理临床实践指南》
Int J Clin Oncol. 2023 Oct;28(10):1333-1342. doi: 10.1007/s10147-023-02375-1. Epub 2023 Jul 7.
10
Post-transplant Lymphoproliferative Disorder (PTLD) in the US Population: Demographics, Treatment Characteristics, and Survival Analysis.美国人群中的移植后淋巴细胞增生性疾病（PTLD）：人口统计学、治疗特征及生存分析。
Cureus. 2023 May 31;15(5):e39777. doi: 10.7759/cureus.39777. eCollection 2023 May.
本文引用的文献
1
Increased incidence of lymphoma after injections of mice with cells differing at weak histocompatibility loci.给小鼠注射在弱组织相容性位点存在差异的细胞后淋巴瘤发病率增加。
Science. 1966 Apr 1;152(3718):78-80. doi: 10.1126/science.152.3718.78.
2
"Immunologic" oncogenesis.
Blood. 1967 Sep;30(3):388-94.
3
Progress in clinical renal homotransplantation.
Adv Surg. 1966;2:419-98.
4
Immunologic rejection of human cancer transplanted with a renal allograft.
N Engl J Med. 1968 Feb 29;278(9):479-83. doi: 10.1056/NEJM196802292780904.
5
Orthotopic liver transplantation in man.人类原位肝移植
Transplant Proc. 1969 Mar;1(1):216-22.
6
Azathioprine (Imuran) administration and the development of malignant lymphomas in NZB mice.硫唑嘌呤（依木兰）给药与NZB小鼠恶性淋巴瘤的发生
Clin Exp Immunol. 1968 May;3(4):305-12.
7
Effects of antilymphocyte serum on virus oncogenesis.抗淋巴细胞血清对病毒致癌作用的影响。
Proc Soc Exp Biol Med. 1968 Jan;127(1):207-12. doi: 10.3181/00379727-127-32657.
8
Perspectives in organ transplantation.
Antibiot Chemother. 1969;15:349-83. doi: 10.1159/000386790.
9
Immunologic disorders in malignant lymphomas.恶性淋巴瘤中的免疫紊乱
Proc Natl Cancer Conf. 1964;5:645-9.
Zotero 插件